Showing 1 - 20 results of 44 for search 'Vivek P Chavda', query time: 0.05s Refine Results
  1. 1
    Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

    Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? by Vivek P. Chavda, Vasso Apostolopoulos

    Published 2022-02-01
    Get full text
    Article
  2. 2
    SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

    SARS-CoV-2: Immunopeptidomics and Other Immunological Studies by Vivek P. Chavda, Elrashdy M. Redwan

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

    Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes by Vivek P. Chavda, Mahesh T. Chhabria, Vasso Apostolopoulos

    Published 2022-07-01
    Get full text
    Article
  4. 4
    A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals

    A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals by Vivek P Chavda, Jack Feehan, Vasso Apostolopoulos

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

    Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2 by Vivek P. Chavda, Toshika Mishra, Suneetha Vuppu

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Inhalable Vaccines: Can They Help Control Pandemics?

    Inhalable Vaccines: Can They Help Control Pandemics? by Vivek P. Chavda, Lalitkumar K. Vora, Vasso Apostolopoulos

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Therapeutics for COVID-19 and post COVID-19 complications: An update

    Therapeutics for COVID-19 and post COVID-19 complications: An update by Debdoot Basu, Vivek P. Chavda, Anita A. Mehta

    Published 2022-01-01
    Get full text
    Article
  8. 8
    The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity

    The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity by Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Pankti Balar

    Published 2023-03-01
    Get full text
    Article
  9. 9
    An Impact of COVID-19 on Cancer Care: An Update

    An Impact of COVID-19 on Cancer Care: An Update by Vivek P. Chavda, Feng-Feng Ping, Zhe-Sheng Chen

    Published 2022-12-01
    Get full text
    Article
  10. 10
    Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena

    Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena by Vivek P. Chavda, Md Kamal Hossain, Jayesh Beladiya, Vasso Apostolopoulos

    Published 2021-10-01
    Get full text
    Article
  11. 11
    Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment

    Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment by Vivek P. Chavda, Normi Gajjar, Nirav Shah, Divyang J. Dave

    Published 2021-12-01
    Get full text
    Article
  12. 12
    A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities

    A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities by Avinash Khadela, Shruti Soni, Kaivalya Megha, Shivam Bhagat, Vivek P. Chavda

    Published 2023-06-01
    Get full text
    Article
  13. 13
    Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

    Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review by Vivek P. Chavda, Jinal Ajabiya, Divya Teli, Joanna Bojarska, Vasso Apostolopoulos

    Published 2022-07-01
    Get full text
    Article
  14. 14
    The Vaccine World of COVID-19: India’s Contribution

    The Vaccine World of COVID-19: India’s Contribution by Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, Vasso Apostolopoulos

    Published 2022-11-01
    Get full text
    Article
  15. 15
    The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far

    The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far by Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang, Tutumoni Kalita

    Published 2022-11-01
    Get full text
    Article
  16. 16
    Peptide-Drug Conjugates: A New Hope for Cancer Management

    Peptide-Drug Conjugates: A New Hope for Cancer Management by Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, Vasso Apostolopoulos, Joanna Bojarska

    Published 2022-10-01
    Get full text
    Article
  17. 17
    Propolis and Their Active Constituents for Chronic Diseases

    Propolis and Their Active Constituents for Chronic Diseases by Vivek P. Chavda, Amit Z. Chaudhari, Divya Teli, Pankti Balar, Lalitkumar Vora

    Published 2023-01-01
    Get full text
    Article
  18. 18
    Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response

    Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response by Avinash Khadela, Vivek P. Chavda, Humzah Postwala, Yesha Shah, Priya Mistry, Vasso Apostolopoulos

    Published 2022-10-01
    Get full text
    Article
  19. 19
    Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer

    Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer by Avinash Khadela, Vivek P. Chavda, Humzah Postwala, Ramya Ephraim, Vasso Apostolopoulos, Yesha Shah

    Published 2023-01-01
    Get full text
    Article
  20. 20
    mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

    mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics by Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash Khadela, Jinal Ajabiya

    Published 2022-12-01
    Get full text
    Article

Search Tools: